This category needs an editor. We encourage you to help if you are qualified.
Volunteer, or read more about what this involves.
Related categories
Subcategories:
280 found
Search inside:
(import / add options)   Sort by:
1 — 50 / 280
Material to categorize
  1. Raymond Anton (2010). Substance Abuse Is a Disease of the Human Brain: Focus on Alcohol. Journal of Law, Medicine and Ethics 38 (4):735-744.
    Alcohol and substance abuse are prevalent in our society. Advances in neuroscience have led to a clearer understanding of the effects of abused substances on the brain. Clues are now available regarding how a person goes from a “user” to being addicted based on brain chemistry, anatomy, and genetic risk. During this process the person loses at least partial, if not complete, control, over their compulsive substance use. This article attempts to put modern notions of alcohol and substance abuse and (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  2. Rebecca Bamford, C. D. Brewer, Bayly Bucknell, Heather DeGrote, Loren Fabry, Madeleine E. M. Hammerlund & Bryan M. Weisbrod (2012). A Paradoxical Ethical Framework for Unpredictable Drug Shortages. American Journal of Bioethics 12 (1):16 - 18.
    The American Journal of Bioethics, Volume 12, Issue 1, Page 16-18, January 2012.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  3. Randy E. Barnett (1984). Review Essay / Public Decisions and Private Rights. Criminal Justice Ethics 3 (2):50-62.
    John Kaplan, The Hardest Drug: Heroin and Public Policy Chicago: The University of Chicago Press, 1983, xi + 247 pp.
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  4. Margaret P. Battin, Erik Luna, Arthur G. Lipman, Paul M. Gahlinger, Douglas E. Rollins, Jeanette C. Roberts & Troy L. Booher (2008). Drugs and Justice: Seeking a Consistent, Coherent, Comprehensive View. OUP USA.
    This compact and innovative book tackles one of the central issues in drug policy: the lack of a coherent conceptual structure for thinking about drugs. Drugs generally fall into one of seven categories: prescription, over the counter, alternative medicine, common-use drugs like alcohol, tobacco and caffeine; religious-use, sports enhancement; and of course illegal street drugs like cocaine and marijuana. Our thinking and policies varies wildly from one to the other, with inconsistencies that derive more from cultural and social values than (...)
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  5. Richard D. Baylis (1994). Drug Utilization Review: A Description of Use for a Medicaid Population (Maryland) 1986?1994. Journal of Law, Medicine and Ethics 22 (3):247-251.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  6. Elizabeth Ben-Ishai (2012). Responding to Vulnerability: The Case of Injection Drug Use. International Journal of Feminist Approaches to Bioethics 5 (2):39-63.
    "Before they were 'junkies,' they were kids." The words appear on a poster, beneath a montage of photographs of children and the text: "Save Insite." Insite, located in Vancouver, Canada, is North America's first and only supervised injection facility (SIF). At Insite, people who use injection drugs can inject previously obtained drugs, such as heroin and cocaine, under medical supervision, using sterile equipment provided by this government-run facility. Opened under the auspices of a three-year exemption from federal drug laws in (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  7. Kim M. Blankenship & Stephen Koester (2002). Criminal Law, Policing Policy, and HIV Risk in Female Street Sex Workers and Injection Drug Users. Journal of Law, Medicine and Ethics 30 (4):548-559.
  8. Walter E. Block & Violet Obioha (2012). War on Black Men: Arguments for the Legalization of Drugs. Criminal Justice Ethics 31 (2):106-120.
    Abstract The leadership of the black community is concerned with welfare, with equality, with unemployment, with discrimination, with racism, with the pay gap, and with dozens of other such traditional issues. Oh, yes, they are also apprehensive about the use of addictive drugs. But, as we speak, young male members of this community are being incarcerated at frightful rates, and, even worse, are killing each other to boot. One would think that this latter issue would occupy the interest of black (...)
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  9. D. Kim Broadwell (1994). The Evolution of Workplace Drug Screening: A Medical Review Officer's Perspective. Journal of Law, Medicine and Ethics 22 (3):240-246.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  10. Olga Bruyaka, Hanko K. Zeitzmann, Isabelle Chalamon, Richard E. Wokutch & Pooja Thakur (2013). Strategic Corporate Social Responsibility and Orphan Drug Development: Insights From the US and the EU Biopharmaceutical Industry. [REVIEW] Journal of Business Ethics 117 (1):45-65.
    In recent years, the biopharmaceutical industry has seen an increase in the development of so-called orphan drugs for the treatment of rare and neglected diseases. This increase has been spurred on by legislation in the United States, Europe, and elsewhere designed to promote orphan drug development. In this article, we examine the drivers of corporate social responsibility (CSR) activities in orphan drug markets and the extent to which biopharmaceutical firms engage in these activities with a strategic orientation. The unique context (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  11. Marc Bygdeman & Marja-Liisa Swahn (1992). Antiprogestin Drugs: Research and Clinical Use in Sweden. Journal of Law, Medicine and Ethics 20 (3):157-160.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  12. Oscar A. Cabrera & Juan Carballo (2013). Tobacco Control Litigation: Broader Impacts on Health Rights Adjudication. Journal of Law, Medicine and Ethics 41 (1):147-162.
    This paper argues that there are instances in which tobacco control litigation is strengthening the justiciability of the right to health and health-related rights. This is happening in different parts of the world, but in particular in Latin America. In part this is because, to a certain extent, tobacco control litigation based on fundamental rights overcomes the traditional arguments against economic, social and cultural rights adjudication: the anti-democratic argument, the lack of technical competency argument, the problem of the misallocation of (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  13. James Chamberlain, Sherri McDonald, Kirk Torgensen & Fay W. Boozman (2004). Methamphetamine: Tools and Partnerships to Fight the Threat. Journal of Law, Medicine and Ethics 32 (s4):104-105.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  14. Eric Chwang (2011). Why Athletic Doping Should Be Banned. Journal of Applied Philosophy 29 (1):33-49.
    So long as a ban is enforceable, large private athletic institutions—such as Major League Baseball and the National Collegiate Athletic Association—should not allow their athletes to take performance-enhancing drugs. The argument I present is game-theoretic: though each athlete prefers unilateral permission to dope over a universal ban, he also prefers a universal ban over universal permission to dope. That is because, while doping improves absolute measures of performance, it does not improve relative performance if many athletes dope. Large private athletic (...)
    Remove from this list | Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  15. Richard Cole (1981). Patients' Right to Refuse Antipsychotic Drugs. Journal of Law, Medicine and Ethics 9 (5):19-22.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  16. Mark Collen (2009). Opioid Contracts and Random Drug Testing for People with Chronic Pain €” Think Twice. Journal of Law, Medicine and Ethics 37 (4):841-845.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  17. Rebecca J. Cook & David A. Grimes (1992). Antiprogestin Drugs: Ethical, Legal and Medical Issues. Journal of Law, Medicine and Ethics 20 (3):149-153.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  18. J. A. Corlett (2013). Taking Drugs Very Seriously. Journal of Medicine and Philosophy 38 (2):235-248.
    Neither anti-illegal drug proponents nor their detractors have wholly plausible arguments for their positions, because neither takes responsibility for drug use sufficiently seriously. Instead, only a policy that places users’ responsibility at the forefront of the problem is acceptable, one that is sufficiently respectful of actual or potential nonusers’ rights not to be wrongfully harmed, directly or indirectly, by drug use, or coerced to support it in any way.
    Remove from this list | Direct download (11 more)  
     
    My bibliography  
     
    Export citation  
  19. Marco Cosentino & Mario Picozzi (2011). The Declaration of Helsinki and Post-Study Access to Effective Drug Treatments for Subjects Participating in Clinical Trials. Bioethics 26 (7):393-394.
    Remove from this list | Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  20. John Davis, William Giakas, Jie Que, Pavan Passad & Stefan Leucht (2011). Should We Treat Depression with Drugs or Psychological Interventions? A Reply to Ioannidis. Philosophy, Ethics, and Humanities in Medicine 6 (1):8-.
    We reply to the Ioannidis's paper "Effectiveness of antidepressants; an evidence based myth constructed from a thousand controlled trials." We disagree that antidepressants have no greater efficacy than placebo. We present the efficacy from hundreds of trials in terms of the percentage of patients with a substantial clinical response (a 50% improvement or more symptomatic reduction). This meta-analysis finds that 42-70% of depressed patients improve with drug and 21%-39% improve with placebo. The response benefit of antidepressant treatment is 33%-11% greater (...)
    Remove from this list |
    Translate to English
    | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  21. Peter de Marneffe (2003). Against the Legalization of Heroin. Criminal Justice Ethics 22 (1):34-40.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  22. David M. Dudzinski (2003). Tobacco Litigation: Statistics Permitted for Proof of Causation and Damages in Class Action. Journal of Law, Medicine and Ethics 31 (1):161-163.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  23. Celia B. Fisher (2003). Adolescent and Parent Perspectives on Ethical Issues in Youth Drug Use and Suicide Survey Research. Ethics and Behavior 13 (4):303 – 332.
    The contributions of adolescent and parent perspectives to ethical planning of survey research on youth drug use and suicide behaviors are highlighted through an empirical examination of 322 7th-12th graders' and 160 parents' opinions on questions related to 4 ethical dimensions of survey research practice: (a)evaluating research risks and benefits, (b)establishing guardian permission requirements, (c)developing confidentiality and disclosure policies, and (d)using cash incentives for recruitment. Generational and ethnic variation in response to questionnaire items developed from discussions within adolescent and parent (...)
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  24. Jessica Flanigan (2013). Adderall for All: A Defense of Pediatric Neuroenhancement. HEC Forum 25 (4):325-344.
    I argue that young patients should be able to access neuroenhancing drugs without a diagnosis of ADHD. The current framework of consent for pediatric patients can be adapted to accommodate neuroenhancement. After a brief overview of pediatric neuroenhancement, I develop three arguments in favor of greater acceptance of neuroenhancement for young patients. First, ADHD is not relevantly different from other disadvantages that could be treated with stimulant medication. Second, establishing a legitimate framework for pediatric neuroenhancement would mitigate the bad effects (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  25. Susan Bartlett Foote (2009). Commentary: Evaluating Oversight of Human Drugs and Medical Devices. Journal of Law, Medicine and Ethics 37 (4):629-632.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  26. Mark S. Frankel (2009). Commentary: Public Outreach by the FDA: Evaluating Oversight of Human Drugs and Medical Devices. Journal of Law, Medicine and Ethics 37 (4):625-628.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  27. Robert J. Fuentes, Art Davis, Barry Sample & Kim Jasper (1994). Sentinel Effect of Drug Testing for Anabolic Steroid Abuse. Journal of Law, Medicine and Ethics 22 (3):224-230.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  28. Jean-Paul Gaudillière (2004). Genesis and Development of a Biomedical Object: Styles of Thought, Styles of Work and the History of the Sex Steroids. Studies in History and Philosophy of Science Part C 35 (3):525-543.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  29. Gerald F. Gaus (1995). Review Essay/Taking Drugs and Rights Seriously. Criminal Justice Ethics 14 (1):63-72.
    Douglas N. Husak, Drugs and Rights. Cambridge: Cambridge University Press, 1992, vii + 312 pp.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  30. Katherine Gehringer (2003). Informed Consent: Hospitals Must Obtain Informed Consent Prior to Drug Testing Pregnant Patients. Journal of Law, Medicine and Ethics 31 (3):455-457.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  31. Harold M. Ginzburg (1986). Intravenous Drug Abusers and HIV Infections: A Consequence of Their Actions. Journal of Law, Medicine and Ethics 14 (5-6):268-272.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  32. Annekathryn Goodman (2012). The Tensions and Challenges of Unpredictable Drug Shortages. American Journal of Bioethics 12 (1):20 - 22.
    The American Journal of Bioethics, Volume 12, Issue 1, Page 20-22, January 2012.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  33. Dov Greenbaum (2012). Patents and Drug Shortages: Will the New Congressional Efforts Save Us From Impending Drug Shortages? American Journal of Bioethics 12 (1):18 - 20.
    The American Journal of Bioethics, Volume 12, Issue 1, Page 18-20, January 2012.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  34. Bridget Haire (2011). Treatment-as-Prevention Needs to Be Considered in the Just Allocation of HIV Drugs. American Journal of Bioethics 11 (12):48-50.
    The American Journal of Bioethics, Volume 11, Issue 12, Page 48-50, December 2011.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  35. A. Hofmann, A. Osman, C. Y. Leow, P. Driguez, D. P. McManus & M. K. Jones (2010). Parasite Annexins – New Molecules with Potential for Drug and Vaccine Development. Bioessays 32 (11):967-976.
    Remove from this list | Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  36. Lester H. Hunt (2003). Epilogue: What Good Are Drugs Anyway? Criminal Justice Ethics 22 (1):46-49.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  37. Elisa A. Hurley (2010). Combat Trauma and the Moral Risks of Memory Manipulating Drugs. Journal of Applied Philosophy 27 (3):221-245.
    To date, 1.7 million US military service personnel have been deployed to Iraq and Afghanistan. Of those, one in five are suffering from diagnosable combat-stress related psychological injuries including Posttraumatic Stress Disorder (PTSD). All indications are that the mental health toll of the current conflicts on US troops and the medical systems that care for them will only increase. Against this backdrop, research suggesting that the common class of drugs known as beta-blockers might prevent the onset of PTSD is drawing (...)
    Remove from this list | Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  38. Douglas Husak (2003). Four Points About Drug Decriminalization. Criminal Justice Ethics 22 (1):21-29.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  39. Douglas N. Husak (1995). [Book Review] Drugs and Rights. [REVIEW] Criminal Justice Ethics 14 (1):63-72.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  40. Marshall B. Kapp (1981). Prescribing Approved Drugs for Nonapproved Uses: Physicians' Disclosure Obligations to Their Patients. Journal of Law, Medicine and Ethics 9 (6):20-23.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  41. William Kay (1976). Drugs and Human Values. Journal of Moral Education 5 (3):295-302.
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  42. Samira Lakhal & Matthew Ja Wood (2011). Exosome Nanotechnology: An Emerging Paradigm Shift in Drug Delivery. Bioessays 33 (10):737-741.
    Remove from this list | Direct download (8 more)  
     
    My bibliography  
     
    Export citation  
  43. Stephen R. Latham (2010). Speaking Off Label. Hastings Center Report 40 (6):9-10.
    In the United States, while it is legal for physicians to prescribe drugs for “off-label” indications (uses for which the drugs do not have Food and Drug Administration approval), it is largely—though not entirely—illegal for drug manufacturers to promote off-label uses of their drugs to physicians. In recent months, the rules against off-label marketing have been rigorously enforced: in October, Allergan reached a $375 million settlement over off-label promotion of Botox; in September, Novartis settled an off-label marketing dispute for $422.5 (...)
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  44. Patrick Lee (2008/2009). Body-Self Dualism in Contemporary Ethics and Politics. Cambridge University Press.
    This book treats the question of what a human person is and the ethical and political controversies of abortion, hedonism and drug-taking, euthanasia, and sex ethics. It defends the position that human beings are both body and soul, with a fundamental and morally important difference from other animals. It defends the traditional position on the most controversial specific moral and political issues of the day.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  45. Jim Leitzel (2013). Toward Drug Control: Exclusion and Buyer Licensing. [REVIEW] Criminal Law and Philosophy 7 (1):99-119.
    The uncertainties associated with the precise nature of legalization regimes and with their expected outcomes sometimes are used to justify the maintenance of drug prohibition. This paper details the role that buyer licensing and exclusion might play in implementing a low-risk, post-prohibition drug regulatory regime. Buyer licensing and exclusion provide assistance to those who exhibit or are worried about self-control problems with drugs, while not being significantly constraining upon those who are informed and satisfied drug consumers. Relative to prohibition, licensing (...)
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  46. Elizabeth Weeks Leonard (2009). Right to Experimental Treatment: FDA New Drug Approval, Constitutional Rights, and the Public's Health. Journal of Law, Medicine and Ethics 37 (2):269-279.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  47. Bebe Loff & Mark Heywood (2002). Patents on Drugs: Manufacturing Scarcity or Advancing Health? Journal of Law, Medicine and Ethics 30 (4):621-631.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  48. Paul A. Logli (1990). Drugs in the Womb: The Newest Battlefield in the War on Drugs. Criminal Justice Ethics 9 (1):23-29.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  49. Ruth Macklin (1992). Antiprogestin Drugs: Ethical Issues. Journal of Law, Medicine and Ethics 20 (3):215-219.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  50. Wendy K. Mariner, Leonard H. Glantz & George J. Annas (1990). Pregnancy, Drugs, and the Perils of Prosecution. Criminal Justice Ethics 9 (1):30-41.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
1 — 50 / 280